Digoxin net secretory transport in bronchial epithelial cell layers is not exclusively mediated by P-glycoprotein/MDR1

Bosquillon, 2010, Drug transporters in the lung – do they play a role in the biopharmaceutics of inhaled drugs?, J. Pharm. Sci., 99, 2240, 10.1002/jps.21995 Forbes, 2011, Challenges in inhaled product development and opportunities for open innovation, Adv. Drug. Deliv. Rev., 63, 69, 10.1016/j.addr.2010.11.004 Sporty, 2008, In vitro cell culture models for the assessment of pulmonary drug disposition, Expert. Opin. Drug. Metab. Toxicol., 4, 333, 10.1517/17425255.4.4.333 Forbes, 2005, Human respiratory epithelial cell culture for drug delivery applications, Eur. J. Pharm. Biopharm., 60, 193, 10.1016/j.ejpb.2005.02.010 Grainger, 2006, Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier, Pharm. Res., 23, 1482, 10.1007/s11095-006-0255-0 Lin, 2007, Air–liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies, J. Pharm. Sci., 96, 341, 10.1002/jps.20803 Mukherjee, 2012, Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro, Int. J. Pharm., 426, 7, 10.1016/j.ijpharm.2011.12.036 Mamlouk, 2013, Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs, J. Asthma, 50, 334, 10.3109/02770903.2013.773518 H.X. Ong, D. Traini, M. Bebawy, P.M. Young, Ciprofloxacin is actively transported across bronchial lung epithelial using a Calu-3 air-interface cell model, Antimicrob. Agents Chemother. (2013) (March 18) (Epub ahead of print). Glaeser, 2011, Importance of P-glycoprotein for drug–drug interactions, Handb. Exp. Pharmacol., 201, 285, 10.1007/978-3-642-14541-4_7 Urquhart, 2009, Blood–brain barrier transporters and response to CNS-active drugs, Eur. J. Clin. Pharmacol., 65, 1063, 10.1007/s00228-009-0714-8 Bleasby, 2006, Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition, Xenobiotica, 36, 963, 10.1080/00498250600861751 Madlova, 2009, In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity, J. Pharm. Pharmacol., 61, 293, 10.1211/jpp.61.03.0003 Haghi, 2010, Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model, Drug. Dev. Ind. Pharm., 36, 1207, 10.3109/03639041003695113 Rautio, 2006, In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates, Drug Metab. Dispos., 34, 786, 10.1124/dmd.105.008615 Huang, 2007, Drug interaction studies: study design, data analysis, and implications for dosing and labeling, Clin. Pharmacol. Ther., 81, 298, 10.1038/sj.clpt.6100054 Manford, 2005, Drug permeability in 16HBE14o-airway cell layers correlates with absorption from the isolated perfused rat lung, Eur. J. Pharm. Sci., 26, 414, 10.1016/j.ejps.2005.07.010 Smith, 2000, MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping, J. Biol. Chem., 275, 23530, 10.1074/jbc.M909002199 Kullak-Ublick, 2001, Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver, Gastroenterology, 120, 525, 10.1053/gast.2001.21176 Mikkaichi, 2004, Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney, Proc. Natl. Acad. Sci. USA, 101, 3569, 10.1073/pnas.0304987101 Yamaguchi, 2010, Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1, Drug Metab. Pharmacokinet., 25, 314, 10.2133/dmpk.25.314 Kimoto, 2011, Characterization of digoxin uptake in sandwich-cultured human hepatocytes, Drug Metab. Dispos., 39, 47, 10.1124/dmd.110.034298 Taub, 2011, Digoxin is not a substrate for organic anion transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium dependent transporter expressed in HEK293 Cells, Drug Metab. Dispos., 39, 2093, 10.1124/dmd.111.040816 Wang, 2008, Application and limitation of inhibitors in drug-transporter interactions studies, Int. J. Pharm., 356, 12, 10.1016/j.ijpharm.2007.12.024 Mease, 2012, Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2, J. Pharm. Sci., 101, 1888, 10.1002/jps.23069 Hilgendorf, 2007, Expression of thrity-six drug transporter genes in human intestine, liver, kidney and organotypic cell lines, Drug Metab. Dispos., 35, 1333, 10.1124/dmd.107.014902 Mechetner, 1997, P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity, Proc. Natl. Acad. Sci. USA, 94, 12908, 10.1073/pnas.94.24.12908 Endter, 2009, RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models, J. Pharm. Pharmacol., 61, 583, 10.1211/jpp.61.05.0006 Kuteykin-Teplyakov, 2010, Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport, Br. J. Pharmacol., 160, 1453, 10.1111/j.1476-5381.2010.00801.x Park, 2003, Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay, Cytometry A, 53, 67, 10.1002/cyto.a.10039 Mechetner, 2007, Detection of the MDR1 P-glycoprotein expression and function, Methods Mol. Biol., 378, 175, 10.1007/978-1-59745-323-3_13 Zhou, 2008, Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development, Curr. Med. Chem., 15, 1981, 10.2174/092986708785132870 Lowes, 2003, Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers, Eur. J. Pharmacol., 458, 49, 10.1016/S0014-2999(02)02764-4 Hamilton, 2001, P-glycoprotein efflux pump expression and activity in Calu-3 cells, J. Pharm. Sci., 90, 647, 10.1002/1520-6017(200105)90:5<647::AID-JPS1021>3.0.CO;2-G Scheffer, 2002, Multidrug resistance related molecules in human and murine lung, J. Clin. Pathol., 55, 332, 10.1136/jcp.55.5.332 Gribar, 2000, Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system, J. Membr. Biol., 173, 203, 10.1007/s002320001020 Sereš, 2011, Tunicamycin depresses p-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in l1210 cells, Int. J. Mol. Sci., 12, 7772, 10.3390/ijms12117772 Draheim, 2010, N-glycosylation of ABC transporters is associated with functional activity in sandwich-cultured rat hepatocytes, Eur. J. Pharm. Sci., 41, 201, 10.1016/j.ejps.2010.06.005 Molnár, 2009, Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp, Acta Histochem., 111, 329, 10.1016/j.acthis.2008.11.010 Kramer, 1995, Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype, Br. J. Cancer, 71, 670, 10.1038/bjc.1995.133 Goda, 2007, Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody, J. Pharmacol. Exp. Ther., 320, 81, 10.1124/jpet.106.110155 Letschert, 2005, Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2, J. Pharmacol. Exp. Therapy, 313, 356, 10.1124/jpet.104.081224 Letschert, 2006, Molecular characterization and inhibition of amanitin uptake into human hepatocytes, Toxicol. Sci., 91, 140, 10.1093/toxsci/kfj141 Childs, 1998, Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein, Cancer Res., 58, 4160 Böhme, 1993, Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane, FEBS Lett., 333, 193, 10.1016/0014-5793(93)80403-H Bourasset, 2003, Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier, J. Neurochem., 86, 1564, 10.1046/j.1471-4159.2003.01990.x Acharya, 2008, Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells, Drug Metab. Dispos., 36, 452, 10.1124/dmd.107.017301 Peters, 2011, Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals, Drug Metab. Dispos., 39, 1643, 10.1124/dmd.111.039206